目次

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Service
1.1.2 End-use
1.1.3 Regional scope
1.1.4 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.3.5.1 Data For Primary Interviews In North America
1.3.5.2 Data For Primary Interviews In Europe
1.3.5.3 Data For Primary Interviews In Asia Pacific
1.3.5.4 Data For Primary Interviews In Latin America
1.3.5.5 Data For Primary Interviews In Mea
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.6.2 Volume Price Analysis (Model 2)
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective - 1
1.10.2 Objective - 2
1.10.3 Objective - 3
1.10.4 Objective - 4

Chapter 2 Executive Summary
2.1 Market Outlook

Chapter 3 Biotechnology and Pharmaceutical Services Outsourcing Market: Variables, Trends, & Scope
3.1 Market Segmentation and Scope
3.2 Market Driver Analysis
3.2.1 Increasing outsourcing of R&D activities
3.2.2 Changing regulatory landscape
3.2.3 Increasing focus on core competencies by pharmaceutical and biotechnology companies
3.2.4 Growing drug development costs coupled with high clinical development failure rates
3.2.5 Increasing mergers and collaborations
3.3 Market Restraint Analysis
3.3.1 Monitoring issues and lack of standardization
3.3.2 Loss of control
3.3.3 Data security issues
3.4 Penetration & Growth Prospect Mapping
3.5 Porter’s Five Forces Analysis
3.6 PESTEL Analysis
3.7 End-use Perception Analysis
3.7.1 Why do you outsource Biotechnology and Pharmaceutical services to CROs?
3.7.2 Percentage of outsourcing of different services.
3.7.3 Importance of CRO selection parameters (Ranking from 1 to 5, where 1 - least important and 5 - most important).
3.8 Service Price Analysis
3.8.1 Pricing strategy
3.8.1.1 Transactional business models
3.8.1.2 Performance-based business models
3.8.1.3 Outcome-based business models
3.8.2 Consulting rates
3.8.3 Heat map for pricing analysis

Chapter 4 Biotechnology and Pharmaceutical Services Outsourcing Market: Service Segment Analysis
4.1 Biotechnology and Pharmaceutical Services Outsourcing: Market Share Analysis, 2021 & 2030
4.2 Consulting
4.2.1 Consulting Market, 2018 - 2030 (USD Million)
4.2.2 Regulatory compliance
4.2.2.1 Regulatory compliance market, 2018 - 2030 (USD Million)
4.2.3 Remediation
4.2.3.1 Remediation market, 2018 - 2030 (USD Million)
4.2.4 Quality management systems consulting
4.2.4.1 Quality management systems consulting market, 2018 - 2030 (USD Million)
4.2.5 Others
4.2.5.1 Others market, 2018 - 2030 (USD Million)
4.3 Auditing and assessment
4.3.1 Auditing and assessment market, 2018 - 2030 (USD Million)
4.4 Regulatory affairs
4.4.1 Regulatory affairs market, 2018 - 2030 (USD Million)
4.4.2 Clinical trial applications & product registration
4.4.2.1 Clinical trial applications & product registration market, 2018 - 2030 (USD Million)
4.4.3 Regulatory writing & publishing
4.4.3.1 Regulatory writing & publishing market, 2018 - 2030 (USD Million)
4.4.4 Legal representation
4.4.4.1 Legal representation market, 2018 - 2030 (USD Million)
4.4.5 Others
4.4.5.1 Others market, 2018 - 2030 (USD Million)
4.5 Product Maintenance
4.5.1 Product maintenance market, 2018 - 2030 (USD Million)
4.6 Product Design & Development
4.6.1 Product Design & Development market, 2018 - 2030 (USD Million)
4.7 Product Testing & Validation
4.7.1 Product Testing & Validation market, 2018 - 2030 (USD Million)
4.8 Training & Education
4.8.1 Training & Education market, 2018 - 2030 (USD Million)
4.9 Others
4.9.1 Others market, 2018 - 2030 (USD Million)

Chapter 5 Biotechnology and Pharmaceutical Services Outsourcing Market: End use Segment Analysis
5.1 Biotechnology and Pharmaceutical Services Outsourcing: Market Share Analysis, 2021 & 2030
5.2 Pharmaceutical Companies
5.2.1 Pharmaceutical Companies market, 2018 - 2030 (USD Million)
5.3 Biotech Companies
5.3.1 Biotech Companies market, 2018 - 2030 (USD Million)

Chapter 6 Biotechnology and Pharmaceutical Services Outsourcing Market: Regional Analysis
6.1 Biotechnology and Pharmaceutical Services Outsourcing: Market Share Analysis, 2021 & 2030
6.2 North America
6.2.1 North America Market, 2018 - 2030 (USD Million)
6.2.2 U.S.
6.2.2.1 U.S. Market, 2018 - 2030 (USD Million)
6.2.3 Canada
6.2.3.1 Canada Market, 2018 - 2030 (USD Million)
6.3 Europe
6.3.1 Europe Market, 2018 - 2030 (USD Million)
6.3.2 U.K.
6.3.2.1 U.K. Market, 2018 - 2030 (USD Million)
6.3.3 Germany
6.3.3.1 Germany Market, 2018 - 2030 (USD Million)
6.3.4 France
6.3.4.1 France Market, 2018 - 2030 (USD Million)
6.3.5 Italy
6.3.5.1 Italy Market, 2018 - 2030 (USD Million)
6.3.6 Spain
6.3.6.1 Spain Market, 2018 - 2030 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific Market, 2018 - 2030 (USD Million)
6.4.2 Japan
6.4.2.1 Japan Market, 2018 - 2030 (USD Million)
6.4.3 China
6.4.3.1 China Market, 2018 - 2030 (USD Million)
6.4.4 India
6.4.4.1 India Market, 2018 - 2030 (USD Million)
6.4.5 Australia
6.4.5.1 Australia Market, 2018 - 2030 (USD Million)
6.4.6 South Korea
6.4.6.1 South Korea Market, 2018 - 2030 (USD Million)
6.5 Latin America
6.5.1 Latin America market, 2018 - 2030 (USD Million)
6.5.2 Brazil
6.5.2.1 Brazil market, 2018 - 2030 (USD Million)
6.5.3 Mexico
6.5.3.1 Mexico market, 2018 - 2030 (USD Million)
6.5.4 Argentina
6.5.4.1 Argentina market, 2018 - 2030 (USD Million)
6.6 MEA
6.6.1 MEA market, 2018 - 2030 (USD Million)
6.6.2 South Africa
6.6.2.1 South Africa market, 2018 - 2030 (USD Million)
6.6.3 Saudi Arabia
6.6.3.1 Saudi Arabia market, 2018 - 2030 (USD Million)
6.6.4 UAE
6.6.4.1 UAE market, 2018 - 2030 (USD Million)

Chapter 7 Competitive Landscape
7.1 Strategy Framework
7.2 Company Profiles
7.2.1 The Quantic Group
7.2.1.1 Company overview
7.2.1.2 Financial performance
7.2.1.3 Service benchmarking
7.2.2 IQVIA HOLDINGS, INC.
7.2.2.1 Company overview
7.2.2.2 Financial performance
7.2.2.3 Service benchmarking
7.2.2.4 Strategic Initiatives
7.2.3 Parexel International Corporation
7.2.3.1Company overview
7.2.3.2 Financial performance
7.2.3.3 Service benchmarking
7.2.3.4 Strategic Initiatives
7.2.4 Lachman Consultant Services
7.2.4.1 Company overview
7.2.4.2 Financial performance
7.2.4.3 Service benchmarking
7.2.5 GMP Pharmaceuticals
7.2.5.1 Company overview
7.2.5.2 Financial performance
7.2.5.3 Service benchmarking
7.2.5.4 Strategic Initiatives
7.2.6 Concept Heidelberg GmbH
7.2.6.1 Company overview
7.2.6.2 Financial performance
7.2.6.3 Service benchmarking
7.2.7 Covance, INC.
7.2.7.1 Company overview
7.2.7.2 Financial performance
7.2.7.3 Service benchmarking
7.2.8 Charles River
7.2.8.1 Company overview
7.2.8.2 Financial performance
7.2.8.3 Service benchmarking
7.2.8.4 Strategic Initiatives
7.2.9 PRA Health Sciences
7.2.9.1 Company overview
7.2.9.2 Financial performance
7.2.9.3 Service benchmarking
7.2.9.4 Strategic Initiatives
7.2.10 ICON plc
7.2.10.1 Company overview
7.2.10.2 Financial performance
7.2.10.3 Service benchmarking
7.2.10.4 Strategic Initiatives

List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global Biotechnology and Pharmaceutical Services Outsourcing Market, By Region, 2018 - 2030 (USD Million)
Table 4 Global Biotechnology and Pharmaceutical Services Outsourcing Market, By Services, 2018 - 2030 (USD Million)
Table 5 Global Biotechnology and Pharmaceutical Services Outsourcing Market, By End Use, 2018 - 2030 (USD Million)
Table 6 North America Biotechnology and Pharmaceutical Services Outsourcing Market, By Country, 2018 - 2030 (USD Million)
Table 7 North America Biotechnology and Pharmaceutical Services Outsourcing Market, By Services, 2018 - 2030 (USD Million)
Table 8 North America Biotechnology and Pharmaceutical Services Outsourcing Market, By End Use, 2018 - 2030 (USD Million)
Table 9 U.S. Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018 - 2030 (USD Million)
Table 10 U.S. Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018 - 2030 (USD Million)
Table 11 Canada Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018 - 2030 (USD Million)
Table 12 Canada Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018 - 2030 (USD Million)
Table 13 Europe Biotechnology and Pharmaceutical Services Outsourcing Market, by Country, 2018 - 2030 (USD Million)
Table 14 Europe Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018 - 2030 (USD Million)
Table 15 Europe Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018 - 2030 (USD Million)
Table 16 U.K. Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018 - 2030 (USD Million)
Table 17 U.K. Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018 - 2030 (USD Million)
Table 18 Germany Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018 - 2030 (USD Million)
Table 19 Germany Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018 - 2030 (USD Million)
Table 20 France Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018 - 2030 (USD Million)
Table 21 France Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018 - 2030 (USD Million)
Table 22 Italy Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018 - 2030 (USD Million)
Table 23 Italy Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018 - 2030 (USD Million)
Table 24 Spain Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018 - 2030 (USD Million)
Table 25 Spain Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018 - 2030 (USD Million)
Table 26 Asia Pacific Biotechnology and Pharmaceutical Services Outsourcing Market, by Country, 2018 - 2030 (USD Million)
Table 27 Asia Pacific Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018 - 2030 (USD Million)
Table 28 Asia Pacific Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018 - 2030 (USD Million)
Table 29 Japan Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018 - 2030 (USD Million)
Table 30 Japan Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018 - 2030 (USD Million)
Table 31 China Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018 - 2030 (USD Million)
Table 32 China Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018 - 2030 (USD Million)
Table 33 India Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018 - 2030 (USD Million)
Table 34 India Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018 - 2030 (USD Million)
Table 35 Australia Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018 - 2030 (USD Million)
Table 36 Australia Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018 - 2030 (USD Million)
Table 37 South Korea Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018 - 2030 (USD Million)
Table 38 South Korea Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018 - 2030 (USD Million)
Table 39 Latin America Biotechnology and Pharmaceutical Services Outsourcing Market, by Country, 2018 - 2030 (USD Million)
Table 40 Latin America Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018 - 2030 (USD Million)
Table 41 Latin America Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018 - 2030 (USD Million)
Table 42 Brazil Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018 - 2030 (USD Million)
Table 43 Brazil Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018 - 2030 (USD Million)
Table 44 Mexico Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018 - 2030 (USD Million)
Table 45 Mexico Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018 - 2030 (USD Million)
Table 46 MEA Biotechnology and Pharmaceutical Services Outsourcing Market, by Country, 2018 - 2030 (USD Million)
Table 47 MEA Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018 - 2030 (USD Million)
Table 48 MEA Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018 - 2030 (USD Million)
Table 49 South Africa Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018 - 2030 (USD Million)
Table 50 South Africa Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018 - 2030 (USD Million)
Table 51 South Arabia Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018 - 2030 (USD Million)
Table 52 South Arabia Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018 - 2030 (USD Million)
Table 53 UAE Biotechnology and Pharmaceutical Services Outsourcing Market, by Services, 2018 - 2030 (USD Million)
Table 54 UAE Biotechnology and Pharmaceutical Services Outsourcing Market, by End Use, 2018 - 2030 (USD Million)

List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value-chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market formulation & validation
Fig. 8 Commodity flow analysis
Fig. 9 Volume price analysis
Fig. 10 Market summary, 2021
Fig. 11 Biotechnology and Pharmaceutical services outsourcing market segmentation
Fig. 12 Parent market outlook
Fig. 13 Ancillary market outlook
Fig. 14 Penetration & growth prospect mapping
Fig. 15 Market driver relevance analysis (Current & future impact)
Fig. 16 Market restraint relevance analysis (Current & future impact)
Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 18 Porter’s five forces analysis
Fig. 19 Biotechnology and Pharmaceutical services outsourcing market: Service movement analysis
Fig. 20 Consulting market, 2018 - 2030 (USD Million)
Fig. 21 Regulatory compliance market, 2018 - 2030 (USD Million)
Fig. 22 Remediation market, 2018 - 2030 (USD Million)
Fig. 23 Quality management systems consulting market, 2018 - 2030 (USD Million)
Fig. 24 Others consulting market, 2018 - 2030 (USD Million)
Fig. 25 Auditing and assessment market, 2018 - 2030 (USD Million)
Fig. 26 Regulatory affairs market, 2018 - 2030 (USD Million)
Fig. 27 Clinical trial applications & product registration market, 2018 - 2030 (USD Million)
Fig. 28 Regulatory writing & publishing market, 2018 - 2030 (USD Million)
Fig. 29 Legal representation market, 2018 - 2030 (USD Million)
Fig. 30 Others market, 2018 - 2030 (USD Million)
Fig. 31 Product maintenance market, 2018 - 2030 (USD Million)
Fig. 32 Product design & development market, 2018 - 2030 (USD Million)
Fig. 33 Product testing & validation market, 2018 - 2030 (USD Million)
Fig. 34 Training & education market, 2018 - 2030 (USD Million)
Fig. 35 Others market, 2018 - 2030 (USD Million)
Fig. 36 Pharma market, 2018 - 2030 (USD Million)
Fig. 37 Biotech market, 2018 - 2030 (USD Million)
Fig. 38 Regional market place: Key takeaways
Fig. 39 Regional outlook, 2020 & 2030
Fig. 40 North America market, 2018 - 2030 (USD Million)
Fig. 41 U.S. market, 2018 - 2030 (USD Million)
Fig. 42 Canada market, 2018 - 2030 (USD Million)
Fig. 43 Europe market, 2018 - 2030 (USD Million)
Fig. 44 U.K. market, 2018 - 2030 (USD Million)
Fig. 45 Germany market, 2018 - 2030 (USD Million)
Fig. 46 France market, 2018 - 2030 (USD Million)
Fig. 47 Italy market, 2018 - 2030 (USD Million)
Fig. 48 Spain market, 2018 - 2030 (USD Million)
Fig. 49 Asia Pacific market, 2018 - 2030 (USD Million)
Fig. 50 Japan market, 2018 - 2030 (USD Million)
Fig. 51 China market, 2018 - 2030 (USD Million)
Fig. 52 India market, 2018 - 2030 (USD Million)
Fig. 53 Australia market, 2018 - 2030 (USD Million)
Fig. 54 South Korea market, 2018 - 2030 (USD Million)
Fig. 55 Latin America market, 2018 - 2030 (USD Million)
Fig. 56 Brazil market, 2018 - 2030 (USD Million)
Fig. 57 Mexico market, 2018 - 2030 (USD Million)
Fig. 58 Argentina market, 2018 - 2030 (USD Million)
Fig. 59 MEA market, 2018 - 2030 (USD Million)
Fig. 60 South Africa market, 2018 - 2030 (USD Million)
Fig. 61 Saudi Arabia market, 2018 - 2030 (USD Million)
Fig. 62 UAE market, 2018 - 2030 (USD Million)